DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum...

M Räisänen; T Karjalainen; H Göransson; A Reito; H Kautiainen; A Malmivaara; OV Leppänen

DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum...

M Räisänen, T Karjalainen, H Göransson, A Reito, H Kautiainen, A Malmivaara, OV Leppänen

TULES-vastuualue

Tutkimustuotos: Artikkeli › Scientific › vertaisarvioitu

Alkuperäiskieli	Englanti
Sivut	e019054
Julkaisu	Bmj Open
Vuosikerta	8
Numero	3
Tila	Julkaistu - 2018
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Julkaisufoorumi-taso

Jufo-taso 1

Pääsy asiakirjaan

https://pubmed.ncbi.nlm.nih.gov/29599391

Siteeraa tätä

Räisänen, M., Karjalainen, T., Göransson, H., Reito, A., Kautiainen, H., Malmivaara, A., & Leppänen, OV. (2018). DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum... Bmj Open, 8(3), e019054. https://pubmed.ncbi.nlm.nih.gov/29599391

Räisänen, M ; Karjalainen, T ; Göransson, H et al. / DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum... Julkaisussa: Bmj Open. 2018 ; Vuosikerta 8, Nro 3. Sivut e019054.

@article{3d91a07b1ae54233a2d72b1ad8fcc19c,

title = "DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum...",

author = "M R{\"a}is{\"a}nen and T Karjalainen and H G{\"o}ransson and A Reito and H Kautiainen and A Malmivaara and OV Lepp{\"a}nen",

year = "2018",

language = "English",

volume = "8",

pages = "e019054",

number = "3",

}

Räisänen, M, Karjalainen, T, Göransson, H, Reito, A, Kautiainen, H, Malmivaara, A & Leppänen, OV 2018, 'DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum...', Bmj Open, Vuosikerta 8, Nro 3, Sivut e019054. <https://pubmed.ncbi.nlm.nih.gov/29599391>

DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum... / Räisänen, M; Karjalainen, T; Göransson, H et al.

julkaisussa: Bmj Open, Vuosikerta 8, Nro 3, 2018, s. e019054.

Tutkimustuotos: Artikkeli › Scientific › vertaisarvioitu

TY - JOUR

T1 - DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum...

AU - Räisänen, M

AU - Karjalainen, T

AU - Göransson, H

AU - Reito, A

AU - Kautiainen, H

AU - Malmivaara, A

AU - Leppänen, OV

PY - 2018

Y1 - 2018

M3 - Article

VL - 8

SP - e019054

IS - 3

ER -